medigraphic.com
SPANISH

Medicina Cutánea Ibero-Latino-Americana

ISSN 0210-5187 (Electronic)
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2006, Number 1

<< Back Next >>

Med Cutan Iber Lat Am 2006; 34 (1)

CD30 negative anaplastic cutaneous lymphoma in association with HTVL-1 infection

Molgó NM, Benedetto EJ, Manríquez MJ, González BS
Full text How to cite this article

Language: Spanish
References: 14
Page: 25-27
PDF size: 171.46 Kb.


Key words:

No keywords

Text Extraction

No abstract


REFERENCES

  1. Shohat M, Hodak E, Hannig H, Bodemer W, David M, Shohat B. Evidence for the cofactor role of human T-cell lymphotropic virus type 1 in mycosis fungoides and Sezary syndrome.Br J Dermatol. 1999;141:44-9.

  2. Yamaguchi T, Ohshima K, Tsuchiya T, Suehuji H, Karube K, Nakayama J, et al. The comparison of expression of cutaneous lymphocyte-associated antigen (CLA), and Th1- and Th2-associated antigens in mycosis fungoides and cutaneous lesions of adult T-cell leukemia/lymphoma. Eur J Dermatol 2003;13:553-9.

  3. Wang C, Yao Z, Liao J, Luo Y, Ma Y, Chen G, et al. Clinicopathologic, immunophenotypic and ultrastructrual analyses of ATLL patients with cutaneous involvement. Chin Med J 1999;112:461.

  4. Johno M, Ono T. Clinicopathological differential diagnosis of mycosis fungoides/Sezary syndrome from the cutaneous type of adult T-cell leukemia/lymphoma. Nipón Rinsho. 2000;58:660-4.

  5. Kimball AB, Chanco Turner ML. Mycosis fungoides and serology for human T-cell lymphotropic virus, type1. J Am Acad Dermatol. 2002;47:159-65.

  6. Dosik H, Denic S, Patel N. Adult T cell leukemia / lymphoma in Brooklyn. JAMA. 1988;259:2255-57.

  7. Cartier L, Mora C, Araya F. HTLV1 positive spactic paraparesis in a temperate zona. Lancet 1989;1:556-57.

  8. Johnson R., Gajdusek D, Morgan O. HTLV1- HTLV2 antibodies and tropical spactis paraparesis. Lancet. 1985;2:1247-1248.

  9. Cabrera ME, Labra S, Meneses P, Matutes E, Cartier L, Ford A, Et al. Leucemia linfoma T del adulto en Chile. Estudio clínico-patológico y molecular de 26 pacientes. Rev Med Chile 1999;127:935-44.

  10. Arisaw K, Katamine S, Kamihira S, Kurokawa K, Sawada T, Soda M. A nested case-control study of risk factors for adult T-cell leukemia/lymphoma among human T-cell lymphotropic virus type-I carriers in Japan.. Cancer Causes Control. 2002;13:657-63.

  11. Ikeda S, Momita S, Kinoshita K, Kamihira S, Moriuchi Y, Tsukasaki K.Clinical course of human T-lymphotropic virus type I carriers with molecularly detectable monoclonal proliferation of T lymphocytes: defining a low- and high-risk population. Blood 1993;82:2017-24.

  12. Yagi H, Takigawa M, Hashizume H. Cutaneous type of adult T cell leukemia/lymphoma: a new entity among cutaneous lymphomas. J Dermatol 2003;30:641-43.

  13. Kato N, Sugawara H, Aoyagi S, Mayuzumi. Lymphoma-type adult T-cell leukaemia-lymphoma with a bulky cutaneous tumour showing multiple human T-lymphotropic virus-1 DNA integration. Br J Dermatol. 2001;144:1244-8.

  14. Demierre M, Kim Y, Zackheim H. Prognosis, clinical outcomes and quality of life issues in cutaneous T-cell lymphoma. Hematol Oncol Clin North Am. 2003;17:1485-507.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Med Cutan Iber Lat Am. 2006;34